Literature DB >> 18712598

Adenine nucleotide hydrolysis in patients with aseptic and bacterial meningitis.

Aracélli Gnatta Dorneles1, Charlene Menezes, Rita Leal Sperotto, Marta Medeiros Frescura Duarte, Vera Maria Morsch, Maria Rosa Chitolina Schetinger, Vânia Lúcia Loro.   

Abstract

The meningitis is a disease with high mortality rates capable to cause neurologic sequelae. The adenosine (the final product of ATP hydrolysis by ectonucleotidases), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions. The aim of the present study was evaluate the adenine nucleotides hydrolysis for to verify one possible role of ATP, ADP and AMP hydrolysis in inflammatory process such as meningitis. The hydrolysis was verified in cerebrospinal fluid (CSF) from human patients with aseptic and bacterial meningitis. Our results showed that the ATP hydrolysis was reduced 12.28% (P < 0.05) in bacterial meningitis and 22% (P < 0.05) in aseptic meningitis. ADP and AMP hydrolysis increased 79.13% (P < 0.05) and 26.37% (P < 0.05) in bacterial meningitis, respectively, and 57.39% (P < 0.05) and 42.64% (P < 0.05) in aseptic meningitis, respectively. This may be an important protective mechanism in order to increase adenosine production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712598     DOI: 10.1007/s11064-008-9807-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  48 in total

1.  Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies.

Authors:  Gilberto Inácio Lunkes; Daniela Lunkes; Francieli Stefanello; André Morsch; Vera Maria Morsch; Cinthia Melazzo Mazzanti; Maria Rosa Chitolina Schetinger
Journal:  Thromb Res       Date:  2003-02-15       Impact factor: 3.944

Review 2.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Authors:  M J L Bours; E L R Swennen; F Di Virgilio; B N Cronstein; P C Dagnelie
Journal:  Pharmacol Ther       Date:  2006-06-19       Impact factor: 12.310

Review 3.  Marked elevation of cerebrospinal fluid white blood cell count: an unusual case of Streptococcus pneumoniae meningitis, differential diagnosis, and a brief review of current epidemiology and treatment recommendations.

Authors:  Jay Menaker; Ian Bebvon K Martin; Jon Mark Hirshon
Journal:  J Emerg Med       Date:  2005-07       Impact factor: 1.484

4.  Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation.

Authors:  L D Todorov; S Mihaylova-Todorova; T D Westfall; P Sneddon; C Kennedy; R A Bjur; D P Westfall
Journal:  Nature       Date:  1997-05-01       Impact factor: 49.962

5.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

Authors:  K M Chan; D Delfert; K D Junger
Journal:  Anal Biochem       Date:  1986-09       Impact factor: 3.365

Review 6.  Trophic effects of purines in neurons and glial cells.

Authors:  M P Rathbone; P J Middlemiss; J W Gysbers; C Andrew; M A Herman; J K Reed; R Ciccarelli; P Di Iorio; F Caciagli
Journal:  Prog Neurobiol       Date:  1999-12       Impact factor: 11.685

7.  Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis.

Authors:  Antonio Rodríguez-Núñez; Elena Cid; Javier Rodríguez-García; Félix Camiña; Santiago Rodríguez-Segade; Manuel Castro-Gago
Journal:  Brain Dev       Date:  2003-03       Impact factor: 1.961

Review 8.  Adenosine in the central nervous system: release mechanisms and extracellular concentrations.

Authors:  S Latini; F Pedata
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

Review 9.  Neuroprotective role of adenosine in cerebral ischaemia.

Authors:  K A Rudolphi; P Schubert; F E Parkinson; B B Fredholm
Journal:  Trends Pharmacol Sci       Date:  1992-12       Impact factor: 14.819

Review 10.  Ecto-enzymes: physiology meets pathology.

Authors:  J W Goding
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.